glp-1 obesity drug news today 2025 Outlook for in 2025: more than a transition year Obesity GLP-1 Market Size to

David Kessler says the new weight-loss drugs are a powerful tool to fight obesity

Compounded GLP-1 drugs are going away Suggested Caption: The shortage of name-brand GLP-1 drugs has ended, and less expensive compounded GLP-1 drugs will no longer be available

Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers...

Discover Pendulum Glucose Control, a probiotic designed to naturally manage blood sugar levels and reduce glucose spikes

Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users